AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04869059 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation
Description: Transcranial direct current stimulation will be delivered via a Neuroelectrics Starstim tES. Stimulation will consist of 1 milliamp stimulation, with anodal stimulation delivered at electrode Fz (International 10/10 System for electroencephalography electrode placement) and electrodes F7, FP1, FP2, and F8 as returns. All electrodes are 1 cm diameter Ag/AgCl electrodes and make contact with the scalp via connective gel. Stimulation will linearly ramp up from 0 milliamps to 1 milliamp over 60 seconds, then remain at 1 milliamp of stimulation over 20 minutes, and finally ramping down at to 0 milliamps over 60 seconds.
Study NCT04869059 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham tDCS
Description: Sham transcranial direct current stimulation will be delivered via a Neuroelectrics Starstim tES. The sham setup will consist of anodal electrode Fz (International 10/10 System for electroencephalography electrode placement) and electrodes F7, FP1, FP2, and F8 as returns. All electrodes are 1 cm diameter Ag/AgCl electrodes and make contact with the scalp via connective gel. Stimulation will linearly ramp up from 0 milliamps to 1 milliamp over 60 seconds, ramp down to 0 milliamps over 60 seconds and then be left off for 20 minutes.
Study NCT06540703 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Therapeutic Ketogenic Diet (TKD)
Description: 2 week induction to establish ketosis followed by 12 weeks therapeutic ketogenic diet
Study NCT06651775 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: High intensity laser therapy
Description: lumbosciatalgia mode of the HILT device
Study NCT06651775 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Comparator
Description: sham mode of the HILT device
Study NCT05709704 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Self-palpation via telehealth
Description: This will be used to determine if the participant has the diagnosis
Study NCT05709704 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Real-time Ultrasound
Description: This will be used in a subgroup of participants to confirm/rule out a diagnosis
Study NCT05998603 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: High protein intake
Description: The participants received a 60g whey protein bolus each evening prior to sleep pre and post a military load carriage test.
Study NCT05998603 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Moderate protein intake
Description: The participants received a 20g whey protein bolus each evening prior to sleep pre and post a military load carriage test.
Study NCT05998603 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Carbohydrate maltodextrin placebo
Description: The participants received an isocaloric carbohydrate bolus each evening prior to sleep pre and post a military load carriage test.
Study NCT05998603 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control no supplementation
Description: Control group, no supplementation, only basic training
Study NCT05350111 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: lifestyle education
Description: education on healthy lifestyle through group sessions and telemedicine tools
Study NCT05747664 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWP16001
Description: 0.3mg
Study NCT04853264 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided peripheral venipuncture
Description: Ultrasound-guided peripheral venipuncture performed by a proficient vascular access registered nurse. The procedure will be performed according to the standard operational protocol for ultrasound guided peripheral venipuncture instituted at the hospital where the study will be conducted. Site Rite 8 or Site Rite 5 ultrasound machines (Bard Access Systems, Inc., USA) will be used on the procedures.
Study NCT04853264 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional peripheral venipuncture
Description: Conventional peripheral venipuncture performed by a registered nurse at the clinical inpatient unit. The procedure will be performed according to the standard operational protocol for peripheral venipuncture instituted in the hospital where the study will be conducted.
Study NCT06050889 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Positive Expectations Instructional Set
Description: Participants randomly assigned to this instructional set will be told, You will be completing an intervention known to be effective for some people with shoulder pain. We expect this will make you less sensitive to the pressure applied to your shoulder and thigh and you will require more pressure than what was previously necessary to experience pain.
Study NCT06050889 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Negative Expectations Instructional Set
Description: Participants randomly assigned to this instructional set will be told, You will be completing an intervention which is not effective for some people with shoulder pain. We expect this will make you more sensitive to the pressure applied to your shoulder and thigh and you will require less pressure than what was previously necessary to experience pain.
Study NCT06341829 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Prismatic adaptation
Description: Participants will fit with prismatic goggles that deviate their visual field by 13° either leftward or rightward. They will seat in front of a white horizontal board on which three target dots (5 mm diameter) were positioned at 0, -10 and +10° from their body midline at a distance of 57 cm from their eyes. They will perform a total of 150 verbally instructed pointing movements with their right index finger towards the right (+10°) and left (-10°) targets in a pseudorandom order.
Study NCT06341829 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Prismatic adaptation
Description: Participants will fit with prismatic goggles that deviate their visual field by 13° either leftward or rightward. They will seat in front of a white horizontal board on which three target dots (5 mm diameter) were positioned at 0, -10 and +10° from their body midline at a distance of 57 cm from their eyes. They will perform a total of 150 verbally instructed pointing movements with their right index finger towards the right (+10°) and left (-10°) targets in a pseudorandom order.
Study NCT06315673 — intervention group
Intervention type: BEHAVIORAL
Intervention: Digital Speech and Handwriting Assessment
Description: Subjects may complete all or some of these tests, depending on functional ability.~* Handwriting battery~* Pattern tracing battery~* Speech Assessment Battery
Study NCT05492227 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Left-overs
Description: Totally nasal swab leftovers were stored from the biobank of Hospital Puerta del Hierro. The coded specimens were kept at -80°C and analyzed using the SARS-CoV-2 NAD Kit. Previously these specimens were analyzed using the gold-standard RT-PCR.
Study NCT06340724 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vonoprazan
Description: 20 mg tablet twice daily
Study NCT06340724 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vonoprazan
Description: 20 mg tablet twice daily
Study NCT06340724 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amoxicillin
Description: 1 g tablet three times daily
Study NCT06099028 — intervention group
Intervention type: OTHER
Intervention: no intervention
Description: no intervention
Study NCT04880460 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Magnesium Glycinate tablet 200mg
Description: Magnesium glycinate tablet 200mg twice daily orally for 8 weeks along with SSRIs
Study NCT04880460 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo tablet 200mg
Description: Placebo tablet 200mg twice daily orally for 8 weeks along with SSRIs
Study NCT06340724 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amoxicillin
Description: 1 g tablet three times daily
Study NCT06340724 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Banxiaxiexin decotion
Description: 100 ml liquid-medicine twice daily
Study NCT05454800 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Scoliosis Specific Corrective Exercises and Physical Activity Counseling
Description: Scoliosis specific corrective exercises and physical activity counseling
Study NCT05529862 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: Pre-treatment biopsy
Description: Pre-treatment fragments will be collected during the biopsy visit organised as part of routine medical practice, prior to the start of treatment with ribociclib + ET
Study NCT05529862 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: Post treatment biopsy
Description: Post-treatment fragments will be collected during a biopsy visit specifically planned for Trans-RosaLEE study.
Study NCT05529862 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: Pre treatment blood sampling
Description: Sampling of 4 EDTA Tubes (4ml) and 2 Streck tubes (10ml)
Study NCT05529862 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: Post treatment blood sampling
Description: Sampling of 2 Streck tubes (10ml)
Study NCT05454800 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Scoliosis Specific Corrective Exercises
Description: Only scoliosis specific corrective exercises
Study NCT06554054 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GZR18
Description: Oral administered the GZR18 tablet
Study NCT05546658 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Psilocybin
Description: Psilocybin administration under supportive conditions
Study NCT05546658 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Psilocybin
Description: Psilocybin administration under supportive conditions
Study NCT06387095 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: 1. no block
Description: After extubation, patient-controlled analgesia will be applied for 24 hours (with PCA infusion pump device). During the follow-up of the patients in intensive care, extubation times, additional analgesic needs, pain scores; intensive care and hospital discharge times will be recorded.
Study NCT06661356 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: COMPrEP
Description: Participants will be paired with peer lay workers and will meet with peer lay workers at private community location. They will discuss options for oral PrEP with peer lay workers and be provided provide daily oral PrEP or event-driven (2-1-1) PrEP. Participants will take part in rapid HIV testing at each visit. They will also meet with peer lay workers at private community location for follow-up at 1,3,6,9, and 12 months
Study NCT06387095 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: 2. superficial parasternal block
Description: After induction, the patient will undergo an ultrasound-guided superficial parasternal plan block. . After extubation, patient-controlled analgesia will be applied for 24 hours (with PCA infusion pump device). During the follow-up of the patients in intensive care, extubation times, additional analgesic needs, pain scores; intensive care and hospital discharge times will be recorded.
Study NCT06387095 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: 3. deep parasternal block
Description: After induction, the patient will undergo an ultrasound-guided deep parasternal plane block. . After extubation, patient-controlled analgesia will be applied for 24 hours (with PCA infusion pump device). During the follow-up of the patients in intensive care, extubation times, additional analgesic needs, pain scores; intensive care and hospital discharge times will be recorded.
Study NCT05533684 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Gabapentin
Description: single preoperative dose of 600 mg gabapentin
Study NCT06347835 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: symbiotic
Description: The intervention is made up of multiple probiotics and prebiotics (20g/d) and dietary pattern modification.
Study NCT06347835 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: whey protein
Description: The intervention is made up of whey protein supplements (20g/d) and dietary pattern modification.
Study NCT06347835 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: symbiotic placebo
Description: The intervention is made up of maltodextrin (20g/d) and dietary pattern modification.
Study NCT06347835 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: symbiotic placebo
Description: The intervention is made up of maltodextrin (20g/d) and dietary pattern modification.
Study NCT06347835 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: whey protein placebo
Description: The intervention is made up of maltodextrin (20g/d) and dietary pattern modification.
Study NCT05662228 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lorazepam
Description: Lorazepam will be administered as an oral pill over the first 15 days of study in a daily titration, starting at 0.5 mg BID and increasing to up to 2 mg three times daily, as tolerated. Dosing will continue at the maximum tolerated dose through the 12-week endpoint. Participants will be titrated off lorazepam over at least four weeks after completing the endpoint visit. Taper will be tailored to individuals for safety reasons with a goal of decreasing dosage by 25% weekly. Phone check ins will be conducted every three days to monitor patient.
Study NCT05662228 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIG)
Description: IVIG will be administered as a series of four intravenous infusions at a dose of 1 mg/kg with pre-infusion medications of 1 mg/kg diphenhydramine and 15 mg/kg acetaminophen. The first two infusions occur at baseline and one day after (induction dosing), followed by one infusion at 4 weeks and one infusion at 8 weeks.
Study NCT05662228 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tofacitinib
Description: Tofacitinib will be administered as an oral pill at 5 mg twice daily over the 12-week study.
Study NCT04489602 — intervention group
Intervention type: OTHER
Intervention: ObsQoR-10F Questionnaire
Description: The ObsQoR-10F questionnaire consists of 10 items assessing different aspects of postpartum recovery: physical comfort and pain, physical independence and emotional status. It takes two minutes to complete all the items. If the patient is not able to read the questionnaire herself, a third person can ask the questions orally to the patient. If the patient has returned home with her child, she can be contacted by phone to complete the questionnaire. Each item is scored from 0 to 10 and the total score is the sum of the score for each item, which is a score from 0 to 110.
Study NCT04993430 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRS8807
Description: HRS8807 monotherapy
Study NCT04993430 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HRS8807、SHR6390
Description: HRS8807 in combination with SHR6390
Study NCT04993430 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRS8807、SHR6390
Description: HRS8807 in combination with SHR6390
Study NCT06659809 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tele-care video-feedback intervention (TVFI)
Description: The TVFI 6 weekly sessions are organized in two subsequent phases: 4 sharing the focus sessions and 2 integration sessions. Sharing the focus sessions are dedicated to the discussion between the psychologist and the mother of specific themes related to parenting and parent-infant interaction: physical stimulation, responsiveness, teaching, and parenting experience. The goal of the sharing the focus sessions is to develop insights about the infants' behavioral signals, the best ways to provide stimulations and get in touch, strategies to promote emotion regulation, and to sustain cognitive and behavioral achievements. In the subsequent two integration sessions, the mother plays with the infant while the psychologist provides guidance based on topics previously discussed during the first four sessions. The goal is to promote a pragmatical translation of the insights developed during the sharing the focus sessions into the interactive exchanges between the mother and the infant.
Study NCT06659003 — intervention group
Intervention type: OTHER
Intervention: Pilot Implementation of Network Canvas into HBH Partner Services
Description: Our team deployed our network data capture software - Network Canvas - into Partner Services at HBH to examine feasibility and acceptability and to provide initial evidence of efficacy (examining impacts on data quality, number of partners notified, and timeliness). Further, our team worked closely with HBH on developing implementation strategies, a Network Canvas interview protocol, evaluation measures, and training materials for their staff. Finally, we provided the HBH team technical support, and regular coaching, supervision, and evaluation.
Study NCT06659302 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: I-inTERACT North Step 1
Description: Initial questionnaires completed followed by initial meeting with therapist for baseline evaluation.
Study NCT06659302 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: I-inTERACT North step 2
Description: Two online modules completed by family plus two online zoom coaching sessions with therapist.
Study NCT06659302 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: I-inTERACT North
Description: Full program will consist of an additional 5 sessions with online modules and virtual coaching sessions with therapist.
Study NCT06658639 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ultrasound lipolysis
Description: Ultrasound lipolysis uses a Luvitra device to emit low-frequency ultrasound pulsed waves. The abdominal area is divided into two sections and the patient is placed in a comfortable supine lying position. The cavitation head is applied slowly to each segment in small circular movements. The treatment lasts 30 minutes on each side, with each session lasting 60 minutes. The same abdominal area is treated every two weeks for three months. The procedure involves cleaning the skin with alcohol cotton.
Study NCT06658639 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cryolipolysis
Description: The study utilized Lipocool, a cryolipolysis apparatus from Korea, with a thermoelectric cooling element. Participants were treated with thermal coupling gel on their abdomen, and the tissue was drawn into the applicator with a moderate vacuum. The device was used for 40-50 minutes, with energy extraction controlled by sensors. The system stopped cold exposure and the clinician released the vacuum. Participants underwent cryolipolysis sessions every 2 weeks for 3 months.
Study NCT06658639 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Low Caloric Diet
Description: A low-calorie diet is a structured plan that restricts daily caloric intake, often used for weight loss. It involves consuming 1,200 to 1,500 calories daily, creating a calorie deficit. However, it requires discipline and safety. The diet is low in fat (20-25%), high in complex carbohydrates (60%), and sufficient in protein (25-50%).
Study NCT06658639 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low Caloric Diet
Description: A low-calorie diet is a structured plan that restricts daily caloric intake, often used for weight loss. It involves consuming 1,200 to 1,500 calories daily, creating a calorie deficit. However, it requires discipline and safety. The diet is low in fat (20-25%), high in complex carbohydrates (60%), and sufficient in protein (25-50%).
Study NCT06658561 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: cold snare polypectomy
Description: Place the special cold snare in the normal mucosa 1-2mm away from the polyp edge. Tighten the snare at a constant speed and gently lift it up and then excision.
Study NCT06658561 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: hot snare polypectomy
Description: According to evaluation of the polyps, directly place the snare on the edge of the polyp including a clear margin of normal tissue (1-2 mm) or after submucosal injection. Tighten the snare at a constant speed and gently lift it up.Use the electrocoagulation and electroscission mode, power on for several seconds until the polyp is cut off.
Study NCT06586138 — intervention group
Intervention type: OTHER
Intervention: STAI (State-Trait Anxiety Inventory) Scale : Psychological inventory of 20 self-report items on a 4-point scale
Description: Patient completed STAI Scale in the 24 hours before Maintenance of Wakefulness Test during the hospitalization
Study NCT06342492 — intervention group
Intervention type: OTHER
Intervention: Coronary Sinus Lead Revision
Description: Coronary Sinus Lead Revision
Study NCT06662305 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Kick-Nic! mobile phone application
Description: The Kick-Nic! app has seven modules that cover core CBT strategies using skills, graphic illustrations, and interactive components to help adolescents quit using e-cigarettes.
Study NCT06662305 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: NCI Quit Vaping website
Description: The NCI webpage provides quitting tobacco resources for youth, including for e-cigarettes. The information provided is similar to the CBT skills modeled by the Kick-Nic! app.
Study NCT05355259 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GECKO Active Guidewire
Description: The GECKO device is intended to introduce devices used for treatment, at a desired anatomical location (cervical carotid artery, for example) in the central circulatory system. The GECKO guidewire itself is not meant to perform a treatment but is used to set the primary access that will allow performance of the treatments.